A multicenter randomized controlled trial to assess the usefulness of computer-aided detection systems for colonoscopy in colorectal cancer screening in the Asia-Pacific region (NCCH2217)

National Cancer Center Hospital, Japan0 个研究点目标入组 1,400 人开始时间: 2023年12月28日最近更新: 2024年1月26日

试验速览

暂无简介。

•Individuals who are scheduled to undergo total colonoscopy for either reason a) or b).
•a) Primary screening colonoscopy for CRC screening
•b) Further colonoscopy due to positive fecal immunochemical test (FIT) upon CRC screening
•Age at entry is between 50 and 79 years.
•ECOG Performance status is 0 or
•Written consent to participate in the study has been obtained.

•Individuals with poorly controlled complications (including unstable angina, post-acute myocardial infarction, heart failure, chronic respiratory disease, bleeding tendency) that make it difficult to safely perform colonoscopy.
•When pathological diagnosis of colorectal lesions is not possible due to reasons such as being on antithrombotic medication and being unable to withdraw the medication
•Clinically suspicious symptoms of CRC, such as bloody stools or abdominal pain
•History of CRC treatment
•History of colorectal surgery involving bowel resection of the colon or rectum (history of surgery not involving bowel resection of the colon or rectum, such as appendectomy for appendicitis, is acceptable)
•Family history of hereditary CRC
•Have or have had inflammatory bowel disease
•Colorectal polyposis
•Have had a colonoscopy within 5 years before the date of registration
•Other cases deemed inappropriate by the doctor in charge

Adenoma detection rate (ADR)

发起方

National Cancer Center Hospital, Japan